<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Baqiyatallah University of Medical Sciences</PublisherName>
				<JournalTitle>Hospital Practices and Research</JournalTitle>
				<Issn>2476-390X</Issn>
				<Volume>4</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>06</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Risk Factors for Surgical Site Infection After Appendectomy for Acute Appendicitis; Results of a Cross-Sectional Study Carried out at a Community Hospital in Qatar (2013-2016)</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>45</FirstPage>
			<LastPage>49</LastPage>
			<ELocationID EIdType="pii">86003</ELocationID>
			
<ELocationID EIdType="doi">10.15171/hpr.2019.08</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Humberto</FirstName>
					<LastName>Guanche Garcell</LastName>
<Affiliation>Infection Control Department, The Cuban Hospital, Hamad Medical Corporation, Doha, Qatar</Affiliation>
<Identifier Source="ORCID">0000-0001-7279-0062</Identifier>

</Author>
<Author>
					<FirstName>Ariadna</FirstName>
					<LastName>Villanueva Arias</LastName>
<Affiliation>Infection Control Department, The Cuban Hospital, Hamad Medical Corporation, Doha, Qatar</Affiliation>

</Author>
<Author>
					<FirstName>Cristobal A.</FirstName>
					<LastName>Pancorbo Sandoval</LastName>
<Affiliation>Surgical Department, The Cuban Hospital, Hamad Medical Corporation, Doha, Qatar</Affiliation>

</Author>
<Author>
					<FirstName>Adam</FirstName>
					<LastName>Bode Sado</LastName>
<Affiliation>Surgical Department, The Cuban Hospital, Hamad Medical Corporation, Doha, Qatar</Affiliation>

</Author>
<Author>
					<FirstName>Ramón Nonato</FirstName>
					<LastName>Alfonso Serrano</LastName>
<Affiliation>Surgical Department, The Cuban Hospital, Hamad Medical Corporation, Doha, Qatar</Affiliation>

</Author>
<Author>
					<FirstName>Francisco</FirstName>
					<LastName>Gutierrez García</LastName>
<Affiliation>Hospital Epidemiology Department, Hospital Joaquín Albarrán, La Habana, Cuba</Affiliation>
<Identifier Source="ORCID">0000-0002-9972-4142</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2018</Year>
					<Month>08</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background:&lt;/strong&gt; Identifying risk factors for surgical site infection (SSI) after appendectomies could be useful in focusing prevention programs.&lt;br /&gt; &lt;strong&gt;Objective:&lt;/strong&gt; The current study aimed to identify the risk factors associated with SSI in a cohort of patients from a single center in Western Qatar.&lt;br /&gt; &lt;strong&gt;Methods:&lt;/strong&gt; This cross-sectional study was carried out at The Cuban Hospital (Dukhan, Qatar) on patients who had undergone an appendectomy from January 2013 through September 2016. Data extracted from the patient files included demographics, comorbidities and toxic habits, surgery type, procedure duration, wound type, appendicitis-type, American Anesthesiology Score, body mass index, selected laboratory tests, and compliance with antibiotic prophylaxis.&lt;br /&gt; &lt;strong&gt;Results:&lt;/strong&gt; The study variables, type of surgery performed, procedure duration, wound and appendicitis type, serum albumin, and timing of antibiotic prophylaxis, were found to be related to the occurrence of SSI in univariate analysis (P = 0.000). Logistic regression showed that open appendectomies (odds ratio [OR] = 22.90, 95% CI; 8.04-65.21), low serum albumin (OR = 0.92, 95% CI; 0.85-0.99), and improper timing of antibiotic prophylaxis (OR = 44.92, 95% CI; 3.39-594.91) were independently associated with the occurrence of SSI.&lt;br /&gt; &lt;strong&gt;Conclusion:&lt;/strong&gt; Cases of complex appendicitis, open procedure, low serum albumin level, and improper timing of antibiotic prophylaxis constituted the risk factors for SSI in the setting of this study. The infection control program should focus on improving the quality of antibiotic prophylaxis and closely monitoring patients who undergo open surgical procedures.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Appendicitis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Appendectomy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Surgical Site Infection</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">risk factors</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Qatar</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.jhpr.ir/article_86003_347d22dbde407699bfc75a6babf9252f.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Baqiyatallah University of Medical Sciences</PublisherName>
				<JournalTitle>Hospital Practices and Research</JournalTitle>
				<Issn>2476-390X</Issn>
				<Volume>4</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>06</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Immunosuppressive Drugs and Kidney Post-transplant Diabetes Mellitus</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>50</FirstPage>
			<LastPage>56</LastPage>
			<ELocationID EIdType="pii">88864</ELocationID>
			
<ELocationID EIdType="doi">10.15171/hpr.2019.09</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ismael Bilal</FirstName>
					<LastName>Ismael</LastName>
<Affiliation>College of Nursing, Hawler Medical University, Erbil, Iraq</Affiliation>

</Author>
<Author>
					<FirstName>Sarhang Hasan</FirstName>
					<LastName>Azeez</LastName>
<Affiliation>Biology Department, College of Education,Salahaddin University-Erbil, Erbil, Iraq</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>01</Month>
					<Day>30</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background: &lt;/strong&gt;As the rate of renal transplantation increases, more immunosuppressive drugs such as cyclosporine A (CsA) are consumed, particularly during the early months following transplantation, leading to post-transplant diabetes mellitus (PTDM) which can cause death.&lt;br /&gt; &lt;strong&gt;Objective: &lt;/strong&gt;The present study examined the role of CsA in causing PTDM and other effective factors among patients with chronic kidney disease (CKD) who had undergone renal replacement therapy.&lt;br /&gt; &lt;strong&gt;Methods: &lt;/strong&gt;The present investigation was a quantitative case-control study carried out on 30 CKD patients who had undergone renal transplantation and 30 healthy individuals. A questionnaire was utilized to gather their demographic information, and direct interviews were conducted with the subjects. To examine random blood sugar (RBS), white blood cell (WBC) count, creatinine level, and blood urea nitrogen (BUN), blood samples were obtained from the subjects. The mentioned parameters were analyzed using SPSS 22.0.&lt;br /&gt; &lt;strong&gt;Results: &lt;/strong&gt;According to the results, the groups were homogenous in age, body mass index (BMI), and male-to-female ratio. However, there were significant differences between the two groups in RBS (&lt;em&gt;P &lt;/em&gt;= 0.011), WBC count (&lt;em&gt;P &lt;/em&gt;= 0.031), creatinine level (&lt;em&gt;P &lt;/em&gt;= 0.001), and BUN (&lt;em&gt;P &lt;/em&gt;= 0.001).&lt;br /&gt; &lt;strong&gt;Conclusion: &lt;/strong&gt;Failure of allograft survival of renal transplantation was found to be a leading cause of death, which has been reportedly been treated by the consumption of immunosuppressive drugs such as CsA. However, this drug can increase the patient’s chances of developing PTDM. PTDM development can be reduced by applying a dosage of 10 mg/kg/d during the first week and 8-9 mg/kg/day during weeks 2-5 following transplantation.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">immunosuppressive agents</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cyclosporine A (CsA)</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Chronic kidney disease</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">renal transplantation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Diabetes Mellitus</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.jhpr.ir/article_88864_069e5fb847a2e11ba6900137b95b76a0.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Baqiyatallah University of Medical Sciences</PublisherName>
				<JournalTitle>Hospital Practices and Research</JournalTitle>
				<Issn>2476-390X</Issn>
				<Volume>4</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>06</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Prevalence of Antibiotic Resistance to Isonicotinylhydrazide and Rifampicin in Culture Positive Pulmonary Tuberculosis Patients from 2014 to 2016 in Zahedan City, Iran</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>57</FirstPage>
			<LastPage>61</LastPage>
			<ELocationID EIdType="pii">89055</ELocationID>
			
<ELocationID EIdType="doi">10.15171/hpr.2019.10</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Seyed Mohammad</FirstName>
					<LastName>Hashemi Shahri</LastName>
<Affiliation>Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-1941-2246</Identifier>

</Author>
<Author>
					<FirstName>Fatemeh</FirstName>
					<LastName>Fardoust</LastName>
<Affiliation>Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Shokoufeh</FirstName>
					<LastName>Mogharabi Ostad Kalayeh</LastName>
<Affiliation>Faculty of Nursing, Islamic Azad University, Iranshahr Branch, Iranshahr, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-0360-4275</Identifier>

</Author>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Ghenaatpisheh Sanani</LastName>
<Affiliation>Faculty of Medical Sciences, Zahedan Branch, Islamic Azad University, Zahedan, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-2160-3794</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>01</Month>
					<Day>05</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background: &lt;/strong&gt;One third of the world’s population is infected with TB, and the disease is known as the second deadly global infection, even more severe than measles. The disease kills about 2 million people a year. Approximately 8 million people in the world are affected by advanced tuberculosis (TB).&lt;br /&gt; &lt;strong&gt;Objective: &lt;/strong&gt;The current study aimed to determine the frequency of resistance to the antibiotics isoniazid and rifampin in positive culture pulmonary TB patients in Zahedan city during 2013-2016.&lt;br /&gt; &lt;strong&gt;Methods: &lt;/strong&gt;This descriptive cross-sectional study studied 100 samples from patients who referred to Boo-Ali hospital of Zahedan city from 2014 to 2016. First, the isoniazid solution was prepared, and then the rifampin solution was prepared. After that, 200 μL of mycobacterium suspension was added to the antibiotic and antibiotic-free control.&lt;br /&gt; &lt;strong&gt;Results: &lt;/strong&gt;Of 100 patients participating in the study, 50 (50%) were male and 50 (50%) were female. Participants had an average age of 51.69 ± 20.41 years (95-12 years), 79 (79%) were Iranians and 21 (21%) were Afghans. Of the 100 samples, 55 (55%) were from the year 2013, 21 (21%) were from 2014, 10 (10%) were from 2015, and 14 (14%) were from year 2016. The samples examined showed that 4 (4%) were resistant and 96% were sensitive.&lt;br /&gt; &lt;strong&gt;Conclusion: &lt;/strong&gt;The results of the current study showed that out of 100 samples, 4 cases (4%) had resistance and 96% were sensitive; 2% were resistant to isoniazid, and 2% were resistant to isoniazid and rifampin.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Pulmonary tuberculosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Drug resistance</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Tuberculosis (TB)</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.jhpr.ir/article_89055_ef5e1017bc505846af791020f272cd4a.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Baqiyatallah University of Medical Sciences</PublisherName>
				<JournalTitle>Hospital Practices and Research</JournalTitle>
				<Issn>2476-390X</Issn>
				<Volume>4</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>06</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The Relationship Between Performance Indicators and Readmission of Patients With Open Heart Surgery: A Case Study in Iran</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>62</FirstPage>
			<LastPage>67</LastPage>
			<ELocationID EIdType="pii">88866</ELocationID>
			
<ELocationID EIdType="doi">10.15171/hpr.2019.11</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Parvin</FirstName>
					<LastName>Ebrahimi</LastName>
<Affiliation>Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-2150-864X</Identifier>

</Author>
<Author>
					<FirstName>Mohammadali</FirstName>
					<LastName>Taghi Nattaj Darzi Naghibi</LastName>
<Affiliation>Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Soudabeh</FirstName>
					<LastName>Vatankhah</LastName>
<Affiliation>Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Ghassem</FirstName>
					<LastName>Faghanzadeh Ganji</LastName>
<Affiliation>Cardiac Surgery Department, Rohani Hospital, Babol University of Medical Sciences, Babol, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>01</Month>
					<Day>30</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background: &lt;/strong&gt;Open heart surgery is a prevalent therapeutic intervention for cardiovascular diseases. Significant adverse effects occur after heart surgery, one of which is patient readmission to the hospital.&lt;br /&gt; &lt;strong&gt;Objective: &lt;/strong&gt;The present study aimed to determine the relationship between performance indicators and the readmission of patients with open heart surgery in a teaching hospital in Iran.&lt;br /&gt; &lt;strong&gt;Methods: &lt;/strong&gt;This study was performed using a cross-sectional and descriptive method with a retrospective approach. Data was collected on a data collection form. The statistical population of this study comprised all patients who underwent open heart surgery from mid-September 2015 to mid-September 2016 in a teaching hospital in the north of Iran (n=849). Those patients readmitted to the hospital within 90 days after discharge, based on a review of patient records, were included in the study. Descriptive statistics and Spearman correlation coefficient were used for data analysis by SPSS 20.&lt;br /&gt; &lt;strong&gt;Results: &lt;/strong&gt;Among the patients who had open heart surgery in the selected hospital, 12.5% were readmitted within 90 days after discharge. The most important reasons for readmission in this study were infection in surgery place (25.8%), pleural effusion (18.7%), warfarin toxicity (9.8%), and tamponade (8.9%). There were inverse relationships between patient readmission and the two performance indicators of bed occupancy percentage (r = -0.594, &lt;em&gt;P &lt;/em&gt;= 0.042) and bed turnover rate (r = -0.664, &lt;em&gt;P &lt;/em&gt;= 0.018). There were no statistically significant relationships between any of the other indicators (length of stay, mortality, and bed turnover interval) and readmission rate (&lt;em&gt;P &lt;/em&gt;&gt; 0.1).&lt;br /&gt; &lt;strong&gt;Conclusion: &lt;/strong&gt;Hospital authorities can use these results for bed management and targeting interventions to reduce costs and readmissions as a measure of hospital quality. However, further research into readmission factors in other hospitals is recommended.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Patient Readmission</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cardiac Surgery</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hospitalization</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Quality indicators</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.jhpr.ir/article_88866_452415094a79de0081ae548a4c89ec50.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Baqiyatallah University of Medical Sciences</PublisherName>
				<JournalTitle>Hospital Practices and Research</JournalTitle>
				<Issn>2476-390X</Issn>
				<Volume>4</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>06</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Atomoxetine Induced Obsessive-Compulsive Disorder</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>68</FirstPage>
			<LastPage>70</LastPage>
			<ELocationID EIdType="pii">82142</ELocationID>
			
<ELocationID EIdType="doi">10.15171/hpr.2019.12</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mengühan</FirstName>
					<LastName>Araz Altay</LastName>
<Affiliation>Department of Child and Adolescent Psychiatry, Trakya University Faculty of Medicine, Edirne, Turkey</Affiliation>
<Identifier Source="ORCID">0000-0001-9433-050X</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2018</Year>
					<Month>09</Month>
					<Day>22</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Introduction: &lt;/strong&gt;Attention deficit and hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children and adolescents. Atomoxetine is a non-stimulant drug used in the treatment of ADHD.&lt;br /&gt; &lt;strong&gt;Case Presentation: &lt;/strong&gt;In this article, a case of obsessive-compulsive disorder (OCD) which occurred in an 11-year-old boy with an increased dose of atomoxetine during ADHD treatment and disappeared with dose reduction is reported. This case is only the second OCD case resulting from the use of atomoxetine.&lt;br /&gt; &lt;strong&gt;Conclusion: &lt;/strong&gt;The case reported herein is the second case caused by the use of atomoxetine and the first in which OCD symptoms regressed when the atomoxetine dose was reduced. OCD development due to atomoxetine consumption may occur at different doses. When OCD develops, the solution may be dose reduction, or it may be necessary to discontinue treatment with atomoxetine.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Atomoxetine Hydrochloride</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Obsessive-compulsive disorder</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Attention Deficit Disorder with Hyperactivity</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Child Psychiatry</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.jhpr.ir/article_82142_d65541d6015ce2ccfd7b77fdc38cf9c8.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Baqiyatallah University of Medical Sciences</PublisherName>
				<JournalTitle>Hospital Practices and Research</JournalTitle>
				<Issn>2476-390X</Issn>
				<Volume>4</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>06</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Transcervical Migration of an Essure® Coil</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>71</FirstPage>
			<LastPage>74</LastPage>
			<ELocationID EIdType="pii">86009</ELocationID>
			
<ELocationID EIdType="doi">10.15171/hpr.2019.13</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Thomas A.</FirstName>
					<LastName>Paterniti</LastName>
<Affiliation>College of Medicine, Florida State University, Orlando, FL, USA</Affiliation>
<Identifier Source="ORCID">0000-0002-6214-331X</Identifier>

</Author>
<Author>
					<FirstName>Lee</FirstName>
					<LastName>Weber</LastName>
<Affiliation>College of Medicine, Florida State University, Orlando, FL, USA</Affiliation>

</Author>
<Author>
					<FirstName>Gene</FirstName>
					<LastName>Krishingner</LastName>
<Affiliation>Women’s and Maternity Care Specialists, Winter Park, FL, USA</Affiliation>

</Author>
<Author>
					<FirstName>Sarfraz</FirstName>
					<LastName>Ahmad</LastName>
<Affiliation>Department of Gynecologic Oncology, Florida Hospital Cancer Institute, Orlando, FL, USA</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2018</Year>
					<Month>11</Month>
					<Day>22</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Introduction: &lt;/strong&gt;Essure&lt;sup&gt;®&lt;/sup&gt; device malposition is a rare, but clinically significant complication, for which management is idiosyncratic. This case report describes an unusual example of Essure&lt;sup&gt;®&lt;/sup&gt; migration in order to clarify reasonable management options.&lt;br /&gt; &lt;strong&gt;Case Presentation: &lt;/strong&gt;A 50-year old G&lt;sub&gt;4&lt;/sub&gt;P&lt;sub&gt;2022&lt;/sub&gt; underwent hysteroscopic sterilization using the Essure&lt;sup&gt;®&lt;/sup&gt; device. Insertion was complicated by fragmentation of both coils. Two years later, one of the coils was incidentally discovered protruding through the cervical os. The visible portion was clipped when attempts to remove the entire coil were unsuccessful.&lt;br /&gt; &lt;strong&gt;Conclusion: &lt;/strong&gt;Difficult placement increases the risk of Essure&lt;sup&gt;®&lt;/sup&gt; malposition. In asymptomatic patients, conservative management with removal of only a portion of the device is a rational approach.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Adverse effects</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Contraceptive Devices</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hysteroscopy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Gynecologic Surgical Procedures</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.jhpr.ir/article_86009_bff871e131877e00d28a79bb36f11ae5.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Baqiyatallah University of Medical Sciences</PublisherName>
				<JournalTitle>Hospital Practices and Research</JournalTitle>
				<Issn>2476-390X</Issn>
				<Volume>4</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>06</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Hurried Psychiatric Labelling: A Preventable Medical Error in an Emergency Department</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>75</FirstPage>
			<LastPage>75</LastPage>
			<ELocationID EIdType="pii">86788</ELocationID>
			
<ELocationID EIdType="doi">10.15171/hpr.2019.14</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mohammad Javad</FirstName>
					<LastName>Behzadnia</LastName>
<Affiliation>Trauma Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-3062-0839</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>01</Month>
					<Day>18</Day>
				</PubDate>
			</History>
		<Abstract></Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Medical error</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">psychiatric</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Emergency Department</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">conversion disorder</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.jhpr.ir/article_86788_815a821cc173d5a74b932ce17ee79bda.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
